40.82 USD
-0.88 (-2.11%)
40.82 USD
0 (0%)
Overall AMEH gets a fundamental rating of 6 out of 10. We evaluated AMEH against 102 industry peers in the Health Care Providers & Services industry. While AMEH has a great health rating, its profitability is only average at the moment. AMEH is growing strongly while it is still valued neutral. This is a good combination! With these ratings, AMEH could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
In the past year AMEH was profitable.
AMEH had a positive operating cash flow in the past year.
AMEH had positive earnings in each of the past 5 years.
In the past 5 years AMEH always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.27%, AMEH is in the better half of the industry, outperforming 74.58% of the companies in the same industry.
Looking at the Return On Equity, with a value of 7.71%, AMEH is in the better half of the industry, outperforming 71.19% of the companies in the same industry.
The Return On Invested Capital of AMEH (7.06%) is better than 75.42% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AMEH is below the industry average of 9.61%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 7.71% | ||
| ROIC | 7.06% |
ROA(3y)6.13%
ROA(5y)4.48%
ROE(3y)12.25%
ROE(5y)10.02%
ROIC(3y)7.61%
ROIC(5y)7.78%
1.3 Margins
AMEH's Profit Margin of 3.45% is fine compared to the rest of the industry. AMEH outperforms 75.42% of its industry peers.
AMEH's Profit Margin has improved in the last couple of years.
The Operating Margin of AMEH (7.61%) is better than 77.97% of its industry peers.
AMEH's Operating Margin has improved in the last couple of years.
The Gross Margin of AMEH (16.34%) is worse than 70.34% of its industry peers.
AMEH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.61% | ||
| PM (TTM) | 3.45% | ||
| GM | 16.34% |
OM growth 3Y14.1%
OM growth 5YN/A
PM growth 3Y19.41%
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y2.84%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AMEH is destroying value.
Compared to 1 year ago, AMEH has more shares outstanding
The debt/assets ratio for AMEH has been reduced compared to a year ago.
2.2 Solvency
AMEH has an Altman-Z score of 4.53. This indicates that AMEH is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.53, AMEH belongs to the top of the industry, outperforming 83.90% of the companies in the same industry.
The Debt to FCF ratio of AMEH is 1.89, which is an excellent value as it means it would take AMEH, only 1.89 years of fcf income to pay off all of its debts.
AMEH has a Debt to FCF ratio of 1.89. This is amongst the best in the industry. AMEH outperforms 85.59% of its industry peers.
AMEH has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.35, AMEH is doing good in the industry, outperforming 65.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 1.89 | ||
| Altman-Z | 4.53 |
ROIC/WACC0.85
WACC8.27%
2.3 Liquidity
AMEH has a Current Ratio of 2.35. This indicates that AMEH is financially healthy and has no problem in meeting its short term obligations.
AMEH's Current ratio of 2.35 is fine compared to the rest of the industry. AMEH outperforms 79.66% of its industry peers.
A Quick Ratio of 2.35 indicates that AMEH has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.35, AMEH belongs to the top of the industry, outperforming 81.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.35 |
3. Growth
3.1 Past
The earnings per share for AMEH have decreased strongly by -29.58% in the last year.
The Earnings Per Share has been growing by 42.03% on average over the past years. This is a very strong growth
Looking at the last year, AMEH shows a very strong growth in Revenue. The Revenue has grown by 27.05%.
AMEH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 81.94% yearly.
EPS 1Y (TTM)-29.58%
EPS 3Y42.03%
EPS 5YN/A
EPS Q2Q%-16.07%
Revenue 1Y (TTM)27.05%
Revenue growth 3Y26.85%
Revenue growth 5Y81.94%
Sales Q2Q%9.84%
3.2 Future
The Earnings Per Share is expected to grow by 15.59% on average over the next years. This is quite good.
Based on estimates for the next years, AMEH will show a very strong growth in Revenue. The Revenue will grow by 26.59% on average per year.
EPS Next Y15.47%
EPS Next 2Y16.56%
EPS Next 3Y15.59%
EPS Next 5YN/A
Revenue Next Year25.04%
Revenue Next 2Y26.5%
Revenue Next 3Y26.59%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 40.82, AMEH can be considered very expensive at the moment.
AMEH's Price/Earnings ratio is a bit cheaper when compared to the industry. AMEH is cheaper than 60.17% of the companies in the same industry.
AMEH is valuated expensively when we compare the Price/Earnings ratio to 26.61, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 28.34, which means the current valuation is very expensive for AMEH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AMEH indicates a somewhat cheap valuation: AMEH is cheaper than 62.71% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.01, AMEH is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.82 | ||
| Fwd PE | 28.34 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMEH indicates a somewhat cheap valuation: AMEH is cheaper than 61.86% of the companies listed in the same industry.
AMEH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AMEH is cheaper than 73.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.06 | ||
| EV/EBITDA | 15.55 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
AMEH has a very decent profitability rating, which may justify a higher PE ratio.
AMEH's earnings are expected to grow with 15.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.64
PEG (5Y)N/A
EPS Next 2Y16.56%
EPS Next 3Y15.59%
5. Dividend
5.1 Amount
No dividends for AMEH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
40.82
-0.88 (-2.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners53.14%
Inst Owner Change3.3%
Ins Owners21.32%
Ins Owner Change0%
Market Cap1.90B
Revenue(TTM)1.33B
Net Income(TTM)45.80M
Analysts83.33
Price Target47.49 (16.34%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.31
Dividend Growth(5Y)N/A
DP7.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.72%
Min EPS beat(2)9.8%
Max EPS beat(2)39.63%
EPS beat(4)3
Avg EPS beat(4)20.8%
Min EPS beat(4)-0.9%
Max EPS beat(4)39.63%
EPS beat(8)6
Avg EPS beat(8)22.78%
EPS beat(12)10
Avg EPS beat(12)32.72%
EPS beat(16)12
Avg EPS beat(16)-118.74%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)-0.17%
Revenue beat(4)2
Avg Revenue beat(4)4.65%
Min Revenue beat(4)-2.49%
Max Revenue beat(4)17.32%
Revenue beat(8)6
Avg Revenue beat(8)8.34%
Revenue beat(12)10
Avg Revenue beat(12)8.2%
Revenue beat(16)12
Avg Revenue beat(16)7.16%
PT rev (1m)4.22%
PT rev (3m)-6.25%
EPS NQ rev (1m)-0.44%
EPS NQ rev (3m)7.6%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.34%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)0.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.82 | ||
| Fwd PE | 28.34 | ||
| P/S | 1.43 | ||
| P/FCF | 17.06 | ||
| P/OCF | 14.21 | ||
| P/B | 3.2 | ||
| P/tB | 7.79 | ||
| EV/EBITDA | 15.55 |
EPS(TTM)1
EY2.45%
EPS(NY)1.44
Fwd EY3.53%
FCF(TTM)2.39
FCFY5.86%
OCF(TTM)2.87
OCFY7.04%
SpS28.49
BVpS12.74
TBVpS5.24
PEG (NY)2.64
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 7.71% | ||
| ROCE | 11.61% | ||
| ROIC | 7.06% | ||
| ROICexc | 10.35% | ||
| ROICexgc | 25.21% | ||
| OM | 7.61% | ||
| PM (TTM) | 3.45% | ||
| GM | 16.34% | ||
| FCFM | 8.4% |
ROA(3y)6.13%
ROA(5y)4.48%
ROE(3y)12.25%
ROE(5y)10.02%
ROIC(3y)7.61%
ROIC(5y)7.78%
ROICexc(3y)12.15%
ROICexc(5y)11.69%
ROICexgc(3y)43.38%
ROICexgc(5y)51.37%
ROCE(3y)12.51%
ROCE(5y)12.79%
ROICexgc growth 3Y1.89%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.67%
ROICexc growth 5YN/A
OM growth 3Y14.1%
OM growth 5YN/A
PM growth 3Y19.41%
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y2.84%
F-Score6
Asset Turnover1.24
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 1.89 | ||
| Debt/EBITDA | 1.76 | ||
| Cap/Depr | 132.23% | ||
| Cap/Sales | 1.68% | ||
| Interest Coverage | 8.45 | ||
| Cash Conversion | 113.54% | ||
| Profit Quality | 243.47% | ||
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.35 | ||
| Altman-Z | 4.53 |
F-Score6
WACC8.27%
ROIC/WACC0.85
Cap/Depr(3y)82.27%
Cap/Depr(5y)51.68%
Cap/Sales(3y)1.55%
Cap/Sales(5y)1.01%
Profit Quality(3y)102.9%
Profit Quality(5y)124.71%
High Growth Momentum
Growth
EPS 1Y (TTM)-29.58%
EPS 3Y42.03%
EPS 5YN/A
EPS Q2Q%-16.07%
EPS Next Y15.47%
EPS Next 2Y16.56%
EPS Next 3Y15.59%
EPS Next 5YN/A
Revenue 1Y (TTM)27.05%
Revenue growth 3Y26.85%
Revenue growth 5Y81.94%
Sales Q2Q%9.84%
Revenue Next Year25.04%
Revenue Next 2Y26.5%
Revenue Next 3Y26.59%
Revenue Next 5YN/A
EBIT growth 1Y7.56%
EBIT growth 3Y44.74%
EBIT growth 5YN/A
EBIT Next Year55.45%
EBIT Next 3Y28.75%
EBIT Next 5YN/A
FCF growth 1Y77.28%
FCF growth 3Y67.35%
FCF growth 5YN/A
OCF growth 1Y67.48%
OCF growth 3Y81.79%
OCF growth 5YN/A
APOLLO MEDICAL HOLDINGS INC / AMEH FAQ
Can you provide the ChartMill fundamental rating for APOLLO MEDICAL HOLDINGS INC?
ChartMill assigns a fundamental rating of 6 / 10 to AMEH.
What is the valuation status for AMEH stock?
ChartMill assigns a valuation rating of 3 / 10 to APOLLO MEDICAL HOLDINGS INC (AMEH). This can be considered as Overvalued.
What is the profitability of AMEH stock?
APOLLO MEDICAL HOLDINGS INC (AMEH) has a profitability rating of 7 / 10.
Can you provide the financial health for AMEH stock?
The financial health rating of APOLLO MEDICAL HOLDINGS INC (AMEH) is 8 / 10.
What is the expected EPS growth for APOLLO MEDICAL HOLDINGS INC (AMEH) stock?
The Earnings per Share (EPS) of APOLLO MEDICAL HOLDINGS INC (AMEH) is expected to grow by 15.47% in the next year.